The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

Chien Wei Peng, Wen Juei Jeng^*

^*此作品的通信作者

研究成果: 期刊稿件 › 快報 › 同行評審

UN SDG

此研究成果有助於以下永續發展目標

@article{b352bc0c35bc49aca84f6c1a8f9c8468,

title = "The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients",

author = "Peng, {Chien Wei} and Jeng, {Wen Juei}",

year = "2021",

month = apr,

doi = "10.1007/s12072-021-10168-9",

language = "英语",

volume = "15",

pages = "527--528",

journal = "Hepatology International",

issn = "1936-0533",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

AU - Peng, Chien Wei

AU - Jeng, Wen Juei

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85104825242&partnerID=8YFLogxK

U2 - 10.1007/s12072-021-10168-9

DO - 10.1007/s12072-021-10168-9

M3 - 快报

C2 - 33904110

AN - SCOPUS:85104825242

SN - 1936-0533

VL - 15

SP - 527

EP - 528

JO - Hepatology International

JF - Hepatology International

IS - 2

ER -